124870-33-3

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-(3-cyanopyridin-4-yl)acetate is used as an intermediate in the synthesis of various pharmaceuticals for its potential biological activities. It serves as a building block in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-(3-cyanopyridin-4-yl)acetate is utilized as an intermediate in the production of agrochemicals. Its potential as an antifungal and antibacterial agent makes it a valuable component in the formulation of pesticides and other agricultural chemicals.
Used in Material Industry:
Methyl 2-(3-cyanopyridin-4-yl)acetate is also used as a precursor in organic synthesis for the development of new materials. Its unique chemical structure allows it to be a key component in the creation of innovative materials with various applications in different industries.
Overall, Methyl 2-(3-cyanopyridin-4-yl)acetate is a multifaceted compound with a wide range of potential applications across the pharmaceutical, agricultural, and material industries, making it an essential component in the development of new products and technologies.

Upstream product

• 5444-01-9 3-cyano-4-methylpyridine 
• 616-38-6 carbonic acid dimethyl ester 
• 100-54-9 pyridine-3-carbonitrile 
• 36850-80-3 [(1-methoxyvinyl)oxy]trimethylsilane 
• 124870-26-4 [1-(tert-Butyl-dimethyl-silanyl)-3-cyano-1,4-dihydro-pyridin-4-yl]-acetic acid methyl ester 

Downstream Products

• 858120-57-7 2-(4-methoxybenzyl)-3,4-dihydro-2,7-naphthyridin-1(2H)-one 

Relevant academic research and scientific papers

CLAY MONTMORILLONITE-CATALYZED REGIOSELECTIVE ADDITION OF SILYL KETENE ACETALS TO PYRIDINE DERIVATIVES: SYNTHESIS OF N-SILYLDIHYDROPYRIDINES

Clay montmorillnite is an effecient catalyst for addition of silyl ketene acetals to pyridine derivatives with electron-withdrawing groups to afford N-silyldihydropyridines.

Azine Activation via Silylium Catalysis

Practical, efficient, and general methods for the diversification of N-heterocycles have been a recurrent goal in chemical synthesis due to the ubiquitous influence of these motifs within bioactive frameworks. Here, we describe a direct, catalytic, and selective functionalization of azines via silylium activation. Our catalyst design enables mild conditions and a remarkable functional group tolerance in a one-pot setup.

METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS

The subject matter described herein is directed to ferroportin inhibitor compounds of Formula (I) and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds, and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis, and also kidney injuries.

17a-HYDROXYLASE/C17,20-LYASE INHIBITORS

The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.

17α-HYDROXYLASE/C17,20-LYASE INHIBITORS

The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.

NOVEL PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

This invention relates to novel pyridine derivatives having an inhibitory effect on production of cytokines, which are involved in inflammatory responses, thus suggesting its usefulness as therapeutic agents for treating diseases related to inflammation, immune, chronic inflammation as well as an agent having an anti-inflammatory and analgesic effect. Further, this invention relates to a method of manufacturing the same and a pharmaceutical composition containing the same.